Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation

Combination therapy of intravenous immunoglobulin (IVIG) and rituximab showed a good transplant rate in highly sensitized wait-listed patients for deceased donor kidney transplantation (DDKT), but carried the risk of antibody-mediated rejection. The authors investigated the impact of a new combinati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Jeong, Jong Cheol, Jambaldorj, Enkthuya, Kwon, Hyuk Yong, Kim, Myung-Gyu, Im, Hye Jin, Jeon, Hee Jung, In, Ji Won, Han, Miyeun, Koo, Tai Yeon, Chung, Junho, Song, Eun Young, Ahn, Curie, Yang, Jaeseok
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2016
Teme:
4500
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748896/
https://ncbi.nlm.nih.gov/pubmed/26844479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002635
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki